Infect Immun 2001,69(6):3916–3923 CrossRefPubMed 13 Conte I, Lab

Infect Immun 2001,69(6):3916–3923.CrossRefPubMed 13. Conte I, Labriola C, Cazzulo JJ, Docampo R, Parodi AJ: The interplay between folding-facilitating mechanisms in Trypanosoma cruzi endoplasmic reticulum. Mol Biol Cell 2003,14(9):3529–3540.CrossRefPubMed selleck chemicals 14. Annoura T, Nara T, Makiuchi T, Hashimoto T, Aoki T: The origin of dihydroorotate dehydrogenase genes of kinetoplastids, with special reference to their biological significance and adaptation to anaerobic, parasitic conditions. J Mol Evol 2005,60(1):113–127.CrossRefPubMed 15. MacRae JI, Obado SO, Turnock DC, Roper JR, Kierans M, Kelly JM, Ferguson MAJ: The suppression of galactose

metabolism in Trypanosoma cruzi epimastigotes causes changes in cell surface molecular architecture and cell morphology. Mol Biochem Parasitol 2006,147(1):126–136.CrossRefPubMed 16. Barrio AB, Van Voorhis WC, BasombrÌo MA: Trypanosoma cruzi: Attenuation of virulence and protective immunogenicity after monoallelic

disruption of the cub gene. Experimental Parasitology 2007,117(4):382–389.CrossRefPubMed 17. Gluenz E, Taylor MC, Kelly JM: The Trypanosoma cruzi metacyclic-specific protein Met-III associates with the nucleolus and contains independent amino and carboxyl terminal targeting elements. Int J Parasitol 2007,37(6):617–625.CrossRefPubMed 18. Wilkinson Selleck PXD101 SR, Taylor MC, Horn D, Kelly JM, Cheeseman I: A mechanism for cross-resistance to nifurtimox and benznidazole in phosphatase inhibitor trypanosomes. Proc Natl Acad Sci USA 2008,105(13):5022–5027.CrossRefPubMed 19. Clayton CE: Genetic manipulation

of kinetoplastida. Parasitol Today 1999,15(9):372–378.CrossRefPubMed 20. DaRocha WD, Otsu K, Teixeira SMR, Donelson JE: Tests of cytoplasmic RNA interference (RNAi) and construction of a tetracycline-inducible T7 promoter system in Trypanosoma cruzi. Mol Biochem Parasitol 2004,133(2):175–186.CrossRefPubMed 21. Bellofatto V, Palenchar JB: RNA interference as a genetic tool in trypanosomes. Methods Mol Biol 2008, 442:83–94.CrossRefPubMed 22. Reche P, Arrebola R, Olmo A, Santi DV, Gonzalez-Pacanowska D, Ruiz-Perez LM: Cloning and expression Histamine H2 receptor of the dihydrofolate reductase-thymidylate synthase gene from Trypanosoma cruzi. Mol Biochem Parasitol 1994,65(2):247–258.CrossRefPubMed 23. Reche P, Arrebola R, Santi DV, Gonzalez-Pacanowska D, Ruiz-Perez LM: Expression and characterization of the Trypanosoma cruzi dihydrofolate reductase domain. Mol Biochem Parasitol 1996,76(1–2):175–185.CrossRefPubMed 24. Anderson AC: Targeting DHFR in parasitic protozoa. Drug Discov Today 2005,10(2):121–128.CrossRefPubMed 25. Cruz A, Coburn CM, Beverley SM: Double targeted gene replacement for creating null mutants. Proc Natl Acad Sci USA 1991,88(16):7170–7174.CrossRefPubMed 26. Sienkiewicz N, Jaroslawski S, Wyllie S, Fairlamb AH: Chemical and genetic validation of dihydrofolate reductase-thymidylate synthase as a drug target in African trypanosomes. Mol Microbiol 2008,69(2):520–533.CrossRefPubMed 27.

Comments are closed.